Regulation of the catecholamine β-adrenergic system in ventricular remodeling of hypertension

Japanese Heart Journal

Volumn 45, Issue 2, 2004, Pages 285-296

  Yingxin, Peng ^a   Jiang, Shan ^a   Xiaoyong, Qi ^b   Hao, Xue ^b   Chunli, Rong ^b   Dongmei, Yao ^b   Zhiqin, Guo ^b   Shiling, Zheng ^b   Min, Wu ^c  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HEBEI GENERAL HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Adrenoceptor; Catecholamine; Cyclic AMP; Hypertension; Ventricular remodeling

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; CYCLIC AMP; NORADRENALIN;

ADRENALIN BLOOD LEVEL; ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE WALL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; BLOOD; CHEMISTRY; ECHOGRAPHY; HYPERTENSION; LYMPHOCYTE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; CYCLIC AMP; ECHOCARDIOGRAPHY; EPINEPHRINE; HUMANS; HYPERTENSION; LYMPHOCYTES; MALE; MIDDLE AGED; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA; VENTRICULAR REMODELING;

EID: 2442645397     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/jhj.45.285     Document Type: Article

References (56)

1. Sundström J, Lind L, Nystrom N, et al. Left ventricular concentric remodeling rather than left ventricular hypertrophy is related to the insulin resistance syndrome in elderly men. Circulation 2000; 101: 2595-601.
2. Cohn JN. Structural changes in cardiovascular diseases. Am J Cardiol 1995; 76: 34E-7.
3. Weber KT, Sun Y, Campbell SE. Structural remodeling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 1995; 16 (Suppl N): 12-8.
4. Verdecchia P, Schillaci G, Borgioni C, et al. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive subjects with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-8.
5. Rumantir MS, Jennings GL, Lambert GW, Kaye DM, Seals DR, Esler MD. The 'adrenaline hypothesis' of hypertension revisited: evidence for adrenaline release from the heart of patients with essential hypertension. J Hypertens 2000; 18: 717-23.
6. Dorn GW. Adrenergic pathways and left ventricular remodeling. J Card Fail 2002; 8 (6 Suppl): S370-3.
7. Jay N. Cohn. Left ventricle and arteries. Hypertension 2001; 37: 346-57.
8. Iwata. M, Yoshikawa. T, Baba. A, et al. Autoimmunity against the second extracellular loop of β1-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circulation Research 2001; 88: 578-86.
9. Julius S, Li Y, Brant D, et al. Neurogenic pressor episodes fail to cause hypertension but do induce cardiac hypertrophy. Hypertension 1989; 13: 422-9.
10. Green L. JNC VI guidelines. Lancet 1998; 351: 288-9.
11. Andren B, Lind L, Hedenstierna G, et al. Left ventricular hypertrophy and geometry in a population sample of elderly males. Eur Heart J 1996; 17: 1800-7.
12. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-8.
13. Levy D, Savage DD, Garrison RJ, et al. Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1987; 59: 956-60.
14. Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1.
15. Shan JR, Fu GH, Lu BZ. The radio ligand binding analysis of adrenoceptors in peripheral lymphocytes. Journal of Military Medicine Academy of Sciences 1988; 1: 73-7.
16. Marcus R, Krause L, Weder AB, et al. Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation 1994; 90: 928-36.
17. Paolisso G, Galzerano D, Gambardella A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995; 25: 529-33.
18. Schroeder AP, Sihm I, Morn B, Thygesen K, Pedersen EB, Lederballe O. Influence of humoral and neurohormonal factors on cardiovascular hypertrophy in untreated essential hypertensives. Am J Hypertens 1996; 9: 207-15.
19. Laks MM, Morady F, Swan HJ. Myocardial hypertrophy produced by chronic infusion of subhypertensive doses of norepinephrine in the dog. Chest 1973; 64: 75-8.
20. Wallukat G. The beta-Adrenergic Receptors. Herz 2002; 27: 683-90.
21. Lohse MJ, Engelhardt S. Protein kinase a transgenes: the many faces of cAMP. Circ Res 2001; 89: 938-40
22. Bristow MR, Anderson FL, Port JD, et al. Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991; 84: 1024-31.
23. Jiang Hong, Dai Guizhu, Feng Zongchen. Regulation of myocardium β-adrenoreceptor pathway in ventricular remodeling of heart failure patients. Natl Med J China 1997; 77: 249-51.
24. 1-adrenoceptor changes in the human heart. J Hypertens 1986; 4 (suppl 6): 215-21.
25. Brodde OE, Kretsch R, Ikezono K, et al. Human beta-adrenoceptors relation between myocardial and lymphocyte β-adrenoceptor density. Science 1986; 231: 1584-91.
26. Maisel AS, Ziegler MG, Carter S, et a. In vivo regulation of beta-adrenerigic receptors on mononuclear leukocytes and heart. J Clin Invest 1988; 82: 2038-44.
27. Briest W, Holzl A, Rassler B, et al. Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovasc Res 2001; 52: 265-73.
28. Müller FU, Boheler KR, Eschenhagen T, Schmitz W, Scholz H. Isoprenaline stimulates gene transcription of the inhibitory G protein-subunit Gi-2 in the rat heart. Circ Res 1993; 72: 696-700.
29. Kudej RK, Iwase M, Uechi M, et al. Effects of chronic β-adrenergic receptor stimulation in mice. J Moll Cell Cardiol 1997; 29: 2735-46.
30. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ. Reciprocal in vivo regulation of myocardial G proteincoupled receptor kinase expression by β-adrenergic receptor stimulation and blockade. Circulation 1998; 98: 1783-9.
31. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci 2000; 97: 6745-50.
32. Yamazaki T, Komuro I, Zou Y, et al. Norepinephrine induces the raf-1 kinase/mitogen-activated protein kinase cascade through both α1-and β-adrenoceptors. Circulation 1997; 95: 1260-8.
33. Peng Y, Ma S, Li Y, Yang L. Relationship left ventricular mass index and β-adrenergic receptor density in peripheral lymphocytes. Chinese Journal of Pathophysiology 1998; 14: 771.
34. Peng Y, Ma S, Li Y, Yang L, Bian S, Zhang S. Changes of β-adrenoreceptors in peripheral lymphocytes at different stages of essential hypertension and their clinical significance [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi 1999, 27: 48-50.
35. Dash R, Kadambi V, Schmidt AG. Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality. Circulation 2001; 103: 889-6.
36. Masami U, Akira SH, Masashi M. Heart rate modulation by sympathetic nerves in dogs with heart failure. Journal of Veterinary Medical Science 2002; 64: 1023-29.
37. Sadoshima J, Yuhui X, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993; 75: 977-84.
38. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-23.
39. 2+ transient and contractile force induced by angiotensin II in aequorin-loaded rabbit ventricular myocardium. Cardiovasc Res 1998; 37: 524-31
40. Boston DR, Koyama T, Rodriguez-Larrain J, Zou A, Su Z, Barry WH. Effects of angiotensin II on intracellular calcium and contracture in metabolically inhibited cardiomyocytes. J Pharmacol Exp Ther 1998; 285: 716-23.
41. Goldsmith SR. Angiotensin II and sympathoactivation in heart failure. J Cardiac Failure 1999; 5: 139-45.
42. Goldsmith SR, Rector TSBAJ, Garr M, Kubo SH. Effect of angiotensin II on noradrenaline release in the human forearm. Cardiovasc Res 1994; 28: 663-6.
43. Clemson B, Gaul L, Gudin S, et al. Prejunctional angiotensin II receptors: facilitation of norepinephrine release in the human forearm. J Clin Invest 1994; 93: 684-91.
44. Brooks VL. Chronic infusion of angiotensin II resets baroreflex control of heart rate by an arterial pressureindependent mechanism. Hypertension 1995; 26: 420-4.
45. Henegar JR, Brower GL, Kabour A, Janicki JS. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol 1995; 269: H1564-9.
46. Henegar JR, Schwartz DD, Janicki JS. Ang II-related myocardial damage: role of cardiac sympathetic catecholamines and β-receptor regulation. Am J Physiol 1998; 275: H534-41.
47. 2-adrenergic receptors. Cardiovasc Drugs Ther. 1999; 13: 123-26.
48. 1-adrenoceptor blockade enhances the activity of the stimulatory G-protein in human atrial myocardium. Br J Pharmacol 1999; 128: 135-41.
49. Thomas CV, Coker ML, Zellner JL, Handy JR, Crumbley AJ3, Spinale FG. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Circulation 1998; 97: 1708-15.
50. Cho MC, Rao M, Koch WJ, Thomas SA, Palmiter RD, Rockman HA. Enhanced contractility and decreased beta-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine. Circulation 1999; 99: 2702-7.
51. Makimoto H, Sakaeda T, Nishiguchi K, et al. Beta 2-adrenergic receptor genotype-related changes in cAMP levels in peripheral blood mononuclear cells after multiple-dose oral procaterol. Pharm Res 2001; 18: 1651-4
52. Woszczek G, Kowalski ML. Genetic polymorphism of beta 2-adrenoreceptor and its role in pathologic states. Postepy Hig Med Dosw 2001; 55: 37-51.
53. 2-Adrenergic receptor overexpression increases alveolar fluid clearance and responsiveness to endogenous catecholamines in rats. Circulation Research 2001; 89: 907-11.
54. Ranade K, Jorgenson E, Sheu WH, et al. A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 2002; 70: 935-42.
55. Wu H, Song X, Xiao J, et al. Two single nucleotide polymorphisms of beta 2-adrenoceptor gene in elderly patients with hypertension [in Chinese]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19: 127-9.
56. 1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 2002; 66: 723-8.